|
Volumn 92, Issue 4 A, 2003, Pages 42-49
|
Regulation of reverse cholesterol transport and clinical implications.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABC TRANSPORTER;
ABC TRANSPORTER A1;
ANTILIPEMIC AGENT;
APOLIPOPROTEIN A1;
CARRIER PROTEIN;
CD36 ANTIGEN;
CETP PROTEIN, HUMAN;
CHOLESTEROL ESTER TRANSFER PROTEIN;
GLYCOPROTEIN;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
IMMUNOGLOBULIN RECEPTOR;
LIPG PROTEIN, HUMAN;
LIPG PROTEIN, MOUSE;
LIPOPROTEIN LIPASE;
LIPOPROTEIN RECEPTOR;
MEMBRANE PROTEIN;
NICOTINIC ACID;
PHOSPHOLIPID TRANSFER PROTEIN;
SCARB1 PROTEIN, MOUSE;
SCAVENGER RECEPTOR;
SCAVENGER RECEPTOR B;
TRIACYLGLYCEROL LIPASE;
ANIMAL;
CARDIOVASCULAR DISEASE;
GENETICS;
HUMAN;
HYPOLIPOPROTEINEMIA;
METABOLISM;
MOUSE;
PHYSIOLOGY;
REVIEW;
RISK FACTOR;
TRANSPORT AT THE CELLULAR LEVEL;
ANIMALS;
ANTIGENS, CD36;
ANTILIPEMIC AGENTS;
APOLIPOPROTEIN A-I;
ATP-BINDING CASSETTE TRANSPORTERS;
BIOLOGICAL TRANSPORT;
CARDIOVASCULAR DISEASES;
CARRIER PROTEINS;
CHOLESTEROL ESTER TRANSFER PROTEINS;
CHOLESTEROL, HDL;
GLYCOPROTEINS;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
HYPOLIPOPROTEINEMIAS;
LIPASE;
LIPOPROTEIN LIPASE;
MEMBRANE PROTEINS;
MICE;
NIACIN;
PHOSPHOLIPID TRANSFER PROTEINS;
RECEPTORS, IMMUNOLOGIC;
RECEPTORS, LIPOPROTEIN;
RECEPTORS, SCAVENGER;
RISK FACTORS;
SCAVENGER RECEPTORS, CLASS B;
|
EID: 0141500234
PISSN: 00029149
EISSN: None
Source Type: Journal
DOI: 10.1016/S0002-9149(03)00615-5 Document Type: Article |
Times cited : (163)
|
References (130)
|